The federal government plans to put an end to the sale of drugs in open markets in the country by the end of next year, Health Minister Isaac Adewole said yesterday.
He said on a visit to the site for the construction of a Pharmaceutical Coordinated Wholesale Centre at Oba, near Onitsha in Anambra State that the recent announcement by government to stop the sale of drugs in open markets is for real.
“May be people still believe that the federal government is joking, government does not joke,” he said.
“We do not want fake drugs or falsified labels; we just want genuine drugs and the only way to do so is centralising the drug market so that we can determine what comes in and what goes out.
“We have agreed to extend the deadline till Dec. 31, 2018 and that will be the last extension. We are irrevocably committed.
“By Jan. 1, 2019, if you are not here at the coordinated centre, then you cannot be anywhere. I am saying it with all seriousness that this is the last extension,” he said.
He commended the Anambra State Government for supporting the project, and urged the leadership of the drug market in the state to settle their disputes amicably.
The minister also lauded the choice of location for the centre, and expressed hope that work on the project would commence immediately to meet the deadline.
Earlier, Adewole, accompanied by Acting Director-General of NAFDAC, Yetunde Oni, had visited the state’s Deputy Governor, Nkem Okeke and Obi of Onitsha, Alfred Achebe.
The minister also visited the traditional ruler of Oba, Peter Ezenwa, before proceeding to the project site.
While receiving the minister, Okeke commended the federal government for its resolve to end open sale of drugs.
He also commended NAFDAC for waging war against fake and counterfeit drugs in the country.
In an interview, the NAFDAC boss called on all stakeholders in drug business to join hands to safeguard the health of the nation.
According to her, the reason for the coordinated centre is to ensure that any drug under the facility is in appropriate drug storage condition.
“Such drugs must be registered, must be of the right quality, safe and efficacious for use because it is impacting on the health and wellbeing of the society,” Oni said.